# State capacity and health system financing: a cross-country analysis

**Authors:** Sumit Mazumdar, Akseer Hussain, Marc Suhrcke, Kanksha Barman, Cameron Feil, Zaad Mahmood

PMC · DOI: 10.1136/bmjgh-2025-020101 · BMJ Global Health · 2026-03-24

## TL;DR

Stronger state institutions are linked to better health financing, with higher public spending and lower out-of-pocket costs for citizens.

## Contribution

This study provides empirical evidence on how multiple dimensions of state capacity affect health system financing globally.

## Key findings

- Stronger state capacity is associated with higher government health expenditure and lower out-of-pocket spending.
- Improvements in bureaucratic quality, government effectiveness, and property rights reduce out-of-pocket health spending.
- A 1 SD increase in state fragility is linked to a 32% decrease in government health expenditure per capita.

## Abstract

Achieving universal health coverage (UHC) requires not only financial resources but also strong and capable states that can mobilise, allocate and effectively manage those resources. Although fiscal capacity is widely acknowledged as a key determinant of health systems financing, state capacity is a broader, multidimensional construct that encompasses the administrative, legal and coercive functions of the state.

This study investigates how multiple dimensions of state capacity—bureaucratic quality, corruption, rule of law, military involvement in politics, government effectiveness, property rights and state fragility—are associated with key measures of health financing. We analyse an unbalanced global panel of 141 countries, including 49 low- and middle-income countries, over the period 2000–2020. Using data from established cross-country institutional and health financing sources, we estimate fixed-effects and random-effects panel regression models to assess the relationship between state capacity and the two health financing metrics: government health expenditure per capita and out-of-pocket health spending as a share of current health expenditure, used here as a proxy for financial protection.

Our findings indicate that stronger state capacity is consistently associated with higher public health investment and reduced out-of-pocket spending by households. A 1 SD increase in bureaucratic quality is associated with a 2.6 percentage-point lower share of OOP health expenditure in current health spending. Similarly, 1 SD improvements in government effectiveness and property rights are associated with 1.6 and 2.8 percentage-point lower OOP shares, respectively. A 1 SD increase in rule of law, government effectiveness or property rights is associated with a 13%–31% higher level of government health expenditure (GHE) per capita, whereas a 1 SD increase in state fragility is associated with a 32% lower GHE per capita. The aggregate state capacity index is positively associated with GHE per capita, with a 1 SD increase corresponding to a 17.5% higher level of public health spending.

The results underscore the critical role of state institutions in achieving sustainable and equitable health financing and highlight the importance of governance reforms in accelerating progress toward UHC across diverse national contexts.

## Full-text entities

- **Genes:** PCSK1 (proprotein convertase subtilisin/kexin type 1) [NCBI Gene 5122] {aka BMIQ12, NEC1, PC1, PC1/3, PC3, SPC3}
- **Diseases:** tuberculosis (MESH:D014376), OOP (MESH:D005888)
- **Chemicals:** GHE (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13034253/full.md

## References

81 references — full list in the complete paper: https://tomesphere.com/paper/PMC13034253/full.md

---
Source: https://tomesphere.com/paper/PMC13034253